Patient enrollment underway for STIMIT’s diaphragm neurostimulation device

STIMIT AG is enrolling patients in a U.S. Food and Drug Administration Investigational Device Exemption (IDE) clinical trial designed to evaluate its noninvasive diaphragm...

Mainstay Medical study demonstrates benefit of neurostimulation for back pain

Mainstay Medical’s one-year study of its neurostimulation system for the treatment of chronic low back pain (CLBP) has demonstrated the system’s value over the...

CardioFocus has positive pulsed field ablation data for its Centauri system

CardioFocus published 12-month data from a study of its pulsed field ablation (PFA) system. ECLIPSE AF, evaluated the safety and performance of the CardioFocus Centauri...

NanoVibronix “achieves goals” of US trial pilot phase with UroShield

NanoVibronix has completed the first phase of a randomised control trial with UroShield, the company’s disposable ultrasound device designed to prevent catheter-associated urinary tract...

CathWorks completes enrolment in CAD treatment system trial

CathWorks completed the enrolment for a randomised controlled trial (RCT), evaluating the FFRangio system in diagnosing and treating coronary artery disease (CAD). The Advancing Cath...

Navigantis achieves 1st cases with VASCO Neurovascular surgical robot

Navigantis achieved the first successful neurovascular clinical cases performed using its VASCO interventional robotic platform for patients with neurovascular disorders. The VASCO interventional robotic platform...

SamanTree Medical’s Histolog scanner shows promise in breast surgery outcomes

SamanTree Medical has revealed that its Histolog scanner, a confocal laser microscope, significantly decreased breast-conserving surgery (BCS) reoperation rates by 67% as observed in...

Protaryx Medical completes first-in-human trial of transseptal puncture device

US-based Protaryx Medical has completed a first-in-human trial of its transseptal puncture (TSP) device. The company’s trial enrolled five patients, with the TSP procedure carried...

EndoQuest wins FDA IDE to study surgical robot in colorectal surgery

EndoQuest Robotics announced it received FDA investigational device exemption (IDE) for a study of its surgical robot. The IDE allows the Houston, Texas-based company...

Latest articles